Latest Articles

Publication Date
Adenomyosis Impact Stigmatizes Women and Demands Urgent Educational Reform - world.infonasional.com

Adenomyosis Impact Stigmatizes Women and Demands Urgent Educational Reform world.infonasional.com

Published: May 20, 2026, 5:12 a.m.
An Unusual Diagnosis of Inguinal Pain in a Childbearing-Age Woman: An Inflamed Canal of Nuck Cyst With an Abnormal Leiomyomatous Proliferation - Cureus

An Unusual Diagnosis of Inguinal Pain in a Childbearing-Age Woman: An Inflamed Canal of Nuck Cyst With an Abnormal Leiomyomatous Proliferation Cureus

Published: May 19, 2026, 5:10 p.m.
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease - Pharmacy Times

GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease Pharmacy Times

Published: May 19, 2026, 3:15 p.m.
Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer - Indian Pharma Post

Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer Indian Pharma Post

Published: May 19, 2026, 9:08 a.m.
Yana Aznavour, MD, PhD, on a non-invasive menstrual blood diagnostic platform for endometriosis - Contemporary OB/GYN

Yana Aznavour, MD, PhD, on a non-invasive menstrual blood diagnostic platform for endometriosis Contemporary OB/GYN

Published: May 18, 2026, 8:17 p.m.
Merck ADC, licensed from China, hits mark in first big global trial - BioPharma Dive

Merck ADC, licensed from China, hits mark in first big global trial BioPharma Dive

Published: May 18, 2026, 4:03 p.m.
Merck, Kelun score with sac-TMT in endometrial cancer trial - Fierce Pharma

Merck, Kelun score with sac-TMT in endometrial cancer trial Fierce Pharma

Published: May 18, 2026, 3:21 p.m.
MSD's Sac-TMT delivers in first phase 3 readout - pharmaphorum

MSD's Sac-TMT delivers in first phase 3 readout pharmaphorum

Published: May 18, 2026, 3:17 p.m.
Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer - PharmaLive

Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer PharmaLive

Published: May 18, 2026, 1:38 p.m.
Expert Insights: Navigating the Influx of New Therapies in Endometrial Cancer - Pharmacy Times

Expert Insights: Navigating the Influx of New Therapies in Endometrial Cancer Pharmacy Times

Published: May 18, 2026, 1:08 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!